Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
ChemBioChem is Scopus-indexed (Q2, CiteScore 4.6), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 1439-4227Verify ISSN ↗1439-7633Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: About US$4,430 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Organic Chemistry | 95 / 215 | 56th | Q2 |
| Biochemistry | 238 / 448 | 46th | Q3 |
| Molecular Biology | 248 / 414 | 40th | Q3 |
| Molecular Medicine | 115 / 179 | 36th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2000–present, best quartile Q2, CiteScore 4.6.
ChemBioChem is Q2 in Organic Chemistry (rank 95 of 215), Q3 in Biochemistry (rank 238 of 448) and Q3 in Molecular Biology (rank 248 of 414), by CiteScore 2025. It is ranked in 4 subject areas in all.
ChemBioChem is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.6, which places it in quartile Q2 at the 56th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.743, quartile Q1, with an H-index of 152.
The publisher lists an article processing charge of about US$4,430 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
ChemBioChem is published by John Wiley and Sons Inc. Its print ISSN is 1439-4227 and its online ISSN is 1439-7633.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
ChemBioChem has an h-index of 162 and a 2-year mean of 2.85 citations per paper (OpenAlex). Its Scopus CiteScore is 4.6, quartile Q2. On 2-year citations it ranks #90 of 210 Scopus journals in Organic Chemistry.
ChemBioChem published 529 papers in 2025; its busiest recent year was 2024 with 583. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from United States (21%), China (17.8%) and Germany (11.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 3 retracted papers are recorded (0.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.